Quantcast

Latest Arbor Pharmaceuticals Stories

2014-03-19 16:23:38

ATLANTA, March 19, 2014 /PRNewswire/ -- Arbor Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing its second New Drug Application (NDA). The NDA was originally filed with the FDA on December 23, 2013 and officially accepted for filing on February 23, 2014. Arbor's first NDA, Nymalize(®) (nimodipine) oral solution, was approved in May of last year. Arbor has a total of seven other branded projects in development consisting of both...

2009-06-02 08:00:00

RALEIGH, N.C., June 2 /PRNewswire/ -- Arbor Pharmaceuticals ("Arbor"), a specialty pharmaceutical company focused exclusively on pediatric medicine, announced today that the company has launched ZINOTIC ES as a new treatment option for Acute Otitis Externa (AOE). ZINOTIC ES is an extra strength formulation of original ZINOTIC intended to provide children suffering from AOE with a greater degree of pain relief and skin protection. ZINOTIC ES is Arbor Pharmaceuticals' fourth product launch in...

2009-02-26 12:00:00

RALEIGH, N.C., Feb. 26 /PRNewswire/ -- Arbor Pharmaceuticals, a specialty pharmaceutical company focused exclusively on pediatric medicine, announced today that the company has launched XYLAREX - a first-in-class nonantibiotic for the dietary management of recurrent acute otitis media (middle ear infections). XYLAREX is a novel oral solution intended to be administered daily to reduce the number of ear infections children experience. The primary ingredient in XYLAREX has also been shown...

2009-01-07 13:56:00

RALEIGH, N.C., Jan. 7 /PRNewswire/ -- Arbor Pharmaceuticals ("Arbor"), an emerging specialty pharmaceutical company focused exclusively on pediatric medicine, announced today that the company recently closed its Series A financing. This latest round of investment capital will support the launch of Arbor's third product and facilitate continued growth of the company and its current and pipeline products. The Series A funding was participated in by several new investors in addition to the...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.